Taruna Katyal | Pharmacology | Best Researcher Award

Dr. Taruna Katyal | Pharmacology | Best Researcher Award

ICMR- India

Author Profile

Early Academic Pursuits 🎓

Dr. Taruna Arora’s journey in the field of pharmacy began with a solid foundation in academic excellence. She earned her Bachelor of Pharmacy (B. Pharm) degree from the Department of Pharmaceutical Sciences at M.D. University, Rohtak, India in 2005, securing a commendable 71%. Driven by a passion for pharmacological research, she pursued her Master of Pharmacy (M. Pharm) in Pharmacology at I.S.F. College of Pharmacy, Punjab Technical University, Jalandhar, graduating in 2007 with an impressive 71%. Her quest for deeper knowledge led her to Uttarakhand Technical University, Dehradun, where she completed her Ph.D. in Pharmacology from 2010 to 2014. Her doctoral research focused on the potential roles of vascular endothelial nitric oxide synthase (eNOS), caveolin-1, and haemoxygenase in the development of experimental diabetic nephropathy in rats, contributing significant insights to the field of diabetic complications and vascular health. This work laid the groundwork for her continued research in the broader field of pharmacology and therapeutic interventions.

Professional Endeavors 🏛️

Dr. Arora’s professional career spans over a decade and showcases her diverse expertise in both academic and research roles. She began as a Lecturer at Shivdan Singh Institute of Management and Technology, Aligarh, in 2007, followed by her position as an Assistant Professor at I.S.F. College of Pharmacy, Moga, Punjab from 2008 to 2012, where she honed her teaching, research, and administrative skills. In 2012, she moved to P.D.M College of Pharmacy, Bahadurgarh, Haryana, serving as an Assistant Professor until 2014, where she was actively involved in nurturing future pharmacists and conducting research.

In 2015, Dr. Arora joined the ICMR National Institute of Malaria Research (NIMR), New Delhi as a Post-Doctoral Fellow, where she conducted pivotal research on the qualitative and quantitative assessment of antimalarials at selected study sites across India. Her tenure at ICMR deepened her research focus on malaria and other infectious diseases, contributing to public health advancements. From 2019 to 2024, Dr. Arora worked as Scientist ‘C’ and later Scientist ‘D’ in the RCN Division of the Indian Council of Medical Research (ICMR), where she coordinated and monitored national task forces, research projects, and fellowships. She also served as the Public Grievance Officer and RTI Officer, ensuring transparency and addressing public concerns effectively. Her responsibilities included compiling monthly research and administrative activities, showcasing her commitment to both scientific and administrative excellence.

Contributions and Research Focus 🔬

Dr. Arora’s research has been impactful, particularly in the areas of pharmacology, malaria elimination, and public health. Her post-doctoral work at ICMR focused on evaluating antimalarial drugs, which have critical implications for effective treatment strategies in endemic regions. Her doctoral work, emphasizing the vascular mechanisms involved in diabetic nephropathy, added valuable data to understand disease progression and potential therapeutic interventions. As a Scientist at ICMR, she contributed to the Malaria Elimination Research Alliance India (MERA INDIA), fostering collaboration between research institutes to push forward malaria elimination goals in India.

Accolades and Recognition 🏆

Dr. Arora’s career has been marked by significant recognition for her contributions. Her involvement in national task forces and leadership in coordinating research projects underscore her expertise and dedication. As a public servant and researcher, she has ensured that scientific research aligns with national health objectives, earning her respect and acknowledgment from peers and the scientific community.

Impact and Influence 🌍

Dr. Arora’s work has had far-reaching effects on public health policies and practices, especially in the area of malaria research and elimination. Her coordination of research initiatives and her strategic input have supported data-driven decisions that contribute to disease control and management. Additionally, her contributions to pharmacological education have shaped the careers of countless students who have benefited from her mentorship and training.

Legacy and Future Contributions 🔮

Dr. Arora’s legacy is one of dedication, scholarship, and an unwavering commitment to public health and pharmacological research. Her work is poised to inspire future generations of researchers and policymakers. As she continues to lead initiatives at ICMR, her impact will undoubtedly resonate in future public health advancements, especially in the context of disease prevention and therapeutic interventions. Dr. Arora’s expertise and experiences provide a roadmap for how research can translate into actionable health outcomes, ensuring her legacy endures in the scientific and health communities.

Citations

A total of 931 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        931
  • h-index          46
  • i10-index       11

Notable Publications 

  • Title: Unveiling the complex interplay between gut microbiota and polycystic ovary syndrome: A narrative review
    Authors: Gautam, R., Maan, P., Patel, A.K., Vasudevan, S., Arora, T.
    Journal: Clinical Nutrition
    Year: 2024.
  • Title: Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
    Authors: Ganie, M.A., Chowdhury, S., Malhotra, N., Arora, T., Kulkarni, B.
    Journal: JAMA network open
    Year: 2024.
  • Title: Unveiling the Role of Artificial Intelligence (AI) in Polycystic Ovary Syndrome (PCOS) Diagnosis: A Comprehensive Review
    Authors: Verma, P., Maan, P., Gautam, R., Arora, T.
    Journal: Reproductive Sciences
    Year: 2024.
  • Title: Adropin may regulate ovarian functions by improving antioxidant potential in adult mouse
    Authors: Maurya, S., Tripathi, S., Arora, T., Singh, A.
    Journal: Journal of Steroid Biochemistry and Molecular Biology
    Year: 2024.
  • Title: Common Hematological Reference Indices Among Healthy Reproductive Age Indian Women-Data Subset from Nationwide Study
    Authors: Ganie, M.A., Chowdhury, S., Suri, V., Shukla, A., Arora, T.
    Journal: Indian Journal of Hematology and Blood Transfusion
    Year: 2024.

Radha Goel | Pharmacology | Best Researcher Award

Dr. Radha Goel | Pharmacology | Best Researcher Award

Lloyd Institute of Management and Technology, Greater Noida, India

Author Profile

🎓 Early Academic Pursuits

Dr. Radha Goel’s academic journey began with a solid foundation in pharmaceutical sciences. She completed her Bachelor of Pharmacy from Hamdard University, New Delhi, in 2002, securing a commendable 67.3%—a significant achievement in a challenging field. Driven by her passion for pharmacology, she further pursued a Master’s degree in Pharmacology at the same university, graduating in 2005 with an impressive 74.8% score. This master’s program provided her with an in-depth understanding of drug interactions, pharmacodynamics, and pharmacokinetics, honing her expertise in pharmacological sciences and setting her on the path to becoming an accomplished researcher and educator.Dr. Goel’s academic journey culminated in a Doctorate in Pharmacology from Jaipur National University in 2012. Her doctoral studies added depth to her research acumen and significantly broadened her knowledge in pharmacology. Additionally, she completed a Post Graduate Diploma in Clinical Research from IGMPI, Gurgaon, in 2016 with a 75.21%, equipping herself with specialized skills crucial for clinical research roles.

👩‍🏫 Professional Endeavors

Dr. Goel’s professional trajectory has been both diverse and impactful, spanning over 17 years in academia and industry. She began her career as a Clinical Research Associate at Jagsonpal Pharmaceuticals Ltd., where she gained hands-on experience in clinical trials and pharmaceutical research from August 2005 to February 2006. This early exposure provided her with practical insights into the industry and set the stage for her transition into academia.In March 2006, Dr. Goel took on her first academic role as a Lecturer at KIET College of Pharmacy, where she remained until August of the same year. Her passion for teaching led her to the Institute of Technology and Science (I.T.S.), Muradnagar, Ghaziabad, where she served in various roles from August 2006 to November 2023. Rising from Lecturer to Assistant Professor, then Associate Professor, and finally Professor, she contributed significantly to the institution’s growth and academic excellence. Currently, she is a Professor at the Lloyd Institute of Management and Technology, Greater Noida, a position she has held since November 11th, 2023, where she continues to inspire the next generation of pharmacologists.

🔬 Contributions and Research Focus

As an educator and researcher, Dr. Goel’s contributions to pharmacology are remarkable. With her background in clinical research and pharmacology, she has focused on areas like drug efficacy, patient safety, and pharmacovigilance, enhancing her students’ understanding of drug interactions, therapeutic protocols, and clinical best practices. Her work as an Animal House In-charge (CCSEA Nominee) is especially noteworthy, as it highlights her commitment to ethical standards in research involving animal subjects, ensuring that all practices comply with regulatory guidelines.Her hands-on approach has allowed her to mentor countless students, guiding them in practical experiments and instilling in them the ethical and technical knowledge required in clinical research. Dr. Goel’s focus on translational research—bridging laboratory findings with clinical applications—continues to influence her teaching, ensuring her students gain real-world insights that enhance their readiness for the pharmaceutical industry.

🏆 Accolades and Recognition

Throughout her career, Dr. Goel has been recognized for her academic and professional achievements. Her expertise in pharmacology and clinical research has made her a sought-after figure in academia, and her appointments to senior roles at various institutions speak to her capabilities and influence. As a CCSEA Nominee and Animal House In-charge, she is acknowledged for her commitment to research ethics and animal welfare in pharmaceutical studies, a role that also reflects her peers’ and students’ respect and trust in her guidance.Dr. Goel’s high performance in her Post Graduate Diploma in Clinical Research from IGMPI and her advanced qualifications in pharmacology have garnered her respect within the academic and research community. Her progression to the role of Professor attests to her dedication, and her continued presence in educational institutions is a testament to her contributions to the field.

🌟 Impact and Influence

Dr. Goel has had a lasting impact on the field of pharmacology, particularly in the Greater Noida and Ghaziabad academic communities. Her deep expertise, combined with a practical approach, has empowered students with knowledge and skills that have helped many succeed in their careers. Her ethical commitment as the Animal House In-charge demonstrates her advocacy for responsible research, influencing a generation of researchers to prioritize ethical standards in their work.Dr. Goel’s influence extends beyond her immediate role as a professor; she has also contributed to academic program development, curriculum enhancement, and the establishment of rigorous academic standards at institutions like I.T.S., Muradnagar, and Lloyd Institute of Management and Technology. Her dedication to fostering a culture of excellence in pharmacology has positively impacted her students, colleagues, and the institutions with which she has been affiliated.

🌍 Legacy and Future Contributions

Looking forward, Dr. Goel’s commitment to pharmacology and clinical research will continue to inspire future healthcare professionals and researchers. Her dedication to educational mentorship, combined with her extensive research experience, positions her to make even greater contributions to the field. As a professor and a leader, she remains a source of guidance and support for her students, helping to mold the future of pharmacology with her knowledge, values, and expertise.In summary, Dr. Radha Goel’s journey from academia to a seasoned professional and dedicated educator stands as a testament to her passion for pharmacology, commitment to ethical research, and her profound influence on students and peers alike. Her story is a reminder of the impact that dedicated educators and researchers can have on their field and the generations to come. 🌱

Citations

A total of 95 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         95
  • h-index           27
  • i10-index        05

Notable Publications 

  • “Nanostructured lipid carriers: Enhancing herbal medicine delivery”
    • Authors: Goel, R., Mishra, R., Singh, N., Singh, R., Gaur, P.K.
    • Journal: Lipid Based Nanocarriers for Drug Delivery, 2024.
  • “Formulation of Phytosomes Containing Rubia cordifolia Extract for Neuropathic Pain: In Vitro and In Vivo Evaluation”
    • Authors: Kumar, N., Goel, R., Ansari, M.N., Puri, D., Singh, M.
    • Journal: ACS Omega, 2024.
  • “Advancing Aluminum-Based Composites with Fly Ash and SiC Reinforcement through Stir Casting”
    • Authors: Abood, A.S., Jisha, P.K., Karuna, G., Goel, R., Chandra, P.K.
    • Journal: E3S Web of Conferences, 2024.
  • “Enhancing Aluminum-Based Composite Manufacturing: Leveraging Si3N4 Reinforcement via Friction Stir Process”
    • Authors: Singh, H., Goel, R., Nagpal, A., Karthiyayini, J., Ahmed, R.
    • Journal: E3S Web of Conferences, 2024.
  • “Nanophytosomal Gel of Heydotis corymbosa (L.) Extract against Psoriasis: Characterisation, In Vitro and In Vivo Biological Activity”
    • Authors: Singh, N., Shaikh, A.M., Gupta, P., Singh, S., Vinayak, C.
    • Journal: Pharmaceuticals, 2024.

Prasad Neerati | Pharmacology | Best Researcher Award

Prof. Prasad Neerati | Pharmacology | Best Researcher Award

Kakatiya University, India

Author Profile

Early Academic Pursuits 🏫

Prof. Neerati Prasad’s academic journey began with a solid foundation in the sciences. He completed his Secondary School Certificate (SSC) in 1991 with a first-class division, securing 74.16% marks. His thirst for knowledge continued as he excelled in his Intermediate studies, achieving 89.53% in 1994 under the Board of Technical Education. His academic journey took a decisive turn when he pursued his undergraduate degree at Kakatiya University, Warangal, where he graduated in 1999 with 65.80% marks. His passion for pharmaceutical sciences grew stronger during his postgraduate studies, also at Kakatiya University, where he emerged as a University Topper 🏆 in 2002, with a distinction and a remarkable 75.50%.Prof. Prasad’s pre-PhD academic qualifications were equally impressive, as he continued his studies at Kakatiya University, securing 70.1% marks in 2007. This solid academic grounding paved the way for his remarkable research career.

Professional Endeavors 👨‍🏫

With 16 years of experience teaching postgraduate (P.G.) classes and 18 years of undergraduate (U.G.) teaching, Prof. Neerati Prasad has been a pillar in the academic world. His dedication to nurturing young minds and guiding them toward excellence is evident in his long-standing role as a professor at Kakatiya University.Beyond teaching, Prof. Prasad’s research contributions have been extensive. He has spent 15 years in research, excluding the years dedicated to his M.Phil. and Ph.D. studies. His research interests are diverse and impactful, spanning Clinical Pharmacokinetics, Drug Transport, Pharmacokinetics and Drug Metabolism, Cancer Metastasis (with a focus on the role of phyto-polyphenols), Toxicological Studies, and the Pharmacological Screening of new chemical entities from natural sources 🌿. These fields of research hold immense significance for the development of novel therapeutic agents, making his work critical for both academia and the pharmaceutical industry.

Contributions and Research Focus 🔬

Prof. Neerati Prasad’s research has been groundbreaking in several key areas. During his M.Pharm., he conducted an insightful study on Bacteremia amongst Leprosy Patients, awarded in June 2002. However, his most notable work came during his Ph.D., where he explored the Isolation and Characterization of probable potential pharmacological agents from animals and their waste. This innovative research, completed in 2007, opened new avenues in pharmacological studies, contributing to the understanding of natural pharmacological agents.Prof. Prasad’s international experience includes his Post-Doctoral Fellowship (PDF) at SRI International in California, USA 🌍. There, he conducted advanced research in Tumor Glycomics, focusing on biomarker discovery, tumor targeting agents, and the regulation of metastasis by endogenous angioinhibitors. His work at the intersection of pharmacology and cancer research has contributed to a better understanding of metastasis and cancer treatment, positioning him as a key researcher in the field of oncology.

Accolades and Recognition 🏅

Prof. Prasad’s academic and research excellence has not gone unnoticed. He is a recipient of the prestigious C.V. Raman Fellowship, awarded by the University Grants Commission (UGC). This fellowship is given to distinguished scholars to encourage high-quality research. Additionally, during his Ph.D. journey, he was awarded a UGC Research Fellowship for his exceptional work. These accolades reflect not only his dedication to the field but also the high regard in which he is held by the academic community.

Impact and Influence 🌍

Prof. Neerati Prasad’s work has had a profound impact on the fields of pharmacology, oncology, and pharmaceutical sciences. His research on Cancer Metastasis and the role of natural compounds in regulating metastasis has been instrumental in developing new approaches to cancer treatment. Moreover, his contributions to Clinical Pharmacokinetics and Drug Metabolism have helped shape the development of safer and more effective drugs.His teaching has influenced countless students who have gone on to pursue successful careers in pharmacy and related fields. Through his mentorship, he has cultivated a generation of researchers and professionals who continue to contribute to the pharmaceutical sciences. His dedication to both teaching and research makes him a well-rounded academic whose influence is felt both inside and outside the classroom. 🎓

Legacy and Future Contributions 🌟

As a seasoned academic and researcher, Prof. Neerati Prasad’s legacy in the field of pharmaceutical sciences is already well-established. However, his journey is far from over. With a continued focus on cutting-edge research in Tumor Glycomics, Drug Transport, and Cancer Metastasis, his work holds the promise of further breakthroughs in these critical areas of healthcare. His research on the Pharmacological Screening of New Chemical Entities from Natural Sources is likely to lead to the discovery of novel therapeutic agents, offering new hope for the treatment of various diseases.In the years to come, Prof. Prasad’s influence will continue to grow as he inspires future generations of pharmacists and researchers. His commitment to advancing pharmaceutical sciences, both in India and internationally, ensures that his contributions will leave a lasting legacy. 🌍

Citations

A total of 667 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         667
  • h-index           41
  • i10-index        16

Notable Publications 

  • Title: A New Epoxy Steroid Isolated and Characterized from Bufo melanostictus Venom with Potential IL-6 along with TNF-α Inhibition and Spectroscopic Study for Structure and Vibrational Properties Using DFT
    Authors: Bonagani, N., Neerati, P., Prashanth, J., Byru, V.R.
    Journal: Journal of Molecular Structure
    Year: 2024.
  • Title: Hypoxia and Extracellular Matrix – Major Drivers of Tumor Metastasis
    Authors: Neerati, P., Polati, D.
    Journal: Hypoxia in Cancer: Significance and Impact on Cancer Therapy (Book Chapter)
    Year: 2023.
  • Title: Novel Indole Derivative as the First P-glycoprotein Inhibitor from the Skin of Indian Toad (Bufo melanostictus)
    Authors: Neerati, P., Munigadapa, S.
    Journal: Turkish Journal of Pharmaceutical Sciences
    Year: 2022.
  • Title: A New Steroidal Derivative from the Skin of Indian Toad (Bufo melanostictus) as a Hypolipidemic and CYP 3A Inhibitor
    Authors: Munigadapa, S.K., Neerati, P.
    Journal: Tropical Journal of Pharmaceutical Research
    Year: 2022.
  • Title: Gallic Acid Improved Amytryptiline Effect in Neuropathic Pain Induced by Partial Sciatic Nerve Ligation (Psnl) in Rats
    Authors: Neerati, P., Enumula, V.
    Journal: Natural Products Journal
    Year: 2021.

PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Dr. PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Vidhyadeep Institute of Pharmacy, Vidhyadeep Univeirsty,Surat India

Author Profile

Early Academic Pursuits 🎓📚

Pranjal Gujarathi’s academic journey in pharmacology began with a deep-rooted interest in the sciences. He pursued a focused path in pharmacy and pharmacology, equipping himself with the knowledge necessary to excel in drug research, pharmacodynamics, and pharmacokinetics. His formal education laid the foundation for his future contributions in understanding drug mechanisms and their effects on biological systems. His commitment to academic excellence ensured that he built a strong grounding in pharmacological principles, which later translated into valuable insights in the field of drug discovery and therapeutic innovations.

Professional Endeavors 🧑‍🔬👨‍🏫

Pranjal Gujarathi has had an impactful professional career in pharmacology, spanning teaching and research roles. He began his professional journey as an Assistant Professor of pharmacology at Shree Dhanvantry Pharmacy College in Surat, Gujarat, from July 27, 2017, to May 15, 2021. During his tenure, Pranjal played a pivotal role in mentoring students, designing course curricula, and advancing the department’s research objectives. His teaching covered various aspects of pharmacology, from drug development to therapeutic applications, helping shape the next generation of pharmacists and pharmacologists.In February 2022, Pranjal transitioned into a Junior Research Fellow position at the same institution, a role that allowed him to dive deeper into pharmacological research. His current work focuses on exploring novel drug therapies, pharmacogenomics, and the development of more effective and safer medications. This shift from teaching to dedicated research underscores his versatility and his dedication to pushing the boundaries of pharmacological knowledge.

Contributions and Research Focus 🔬💉

Pranjal Gujarathi’s research has primarily revolved around drug discovery, preclinical studies, and pharmacodynamics, areas where he has made significant contributions. His work emphasizes the understanding of drug-receptor interactions, drug metabolism, and toxicology, all of which are crucial in the early stages of drug development. His role as a Junior Research Fellow allows him to collaborate with other scientists to test the efficacy and safety of new drug formulations before they enter clinical trials.His research is also centered on immunopharmacology and neuropharmacology, focusing on conditions like psoriasis and neurodegenerative diseases. These diseases represent significant challenges in pharmacotherapy, and Pranjal’s preclinical work has helped pave the way for potential breakthroughs in treatment. His expertise in pharmacokinetics, which studies how drugs move through the body, further enhances the precision of his research, allowing for more targeted and effective treatments.

Accolades and Recognition 🏆📜

Pranjal Gujarathi has been widely recognized for his contributions to pharmacology. His research has been published in esteemed journals such as International Immunopharmacology and Naunyn-Schmiedeberg’s Archives of Pharmacology. These publications highlight his growing influence in the scientific community, particularly in the areas of drug discovery in psoriasis and comprehensive studies on Hypericum perforatum in treating neurodegenerative diseases.His academic prowess and ability to translate complex pharmacological concepts into applied research have earned him accolades at conferences and symposia, where his papers have been well-received. These recognitions validate his dedication to advancing the field of pharmacology and underscore his commitment to improving public health through better pharmaceuticals.

Impact and Influence 🌍💊

Pranjal’s influence extends beyond the confines of academia and research. As an educator, he has inspired countless students to pursue careers in pharmacology, instilling in them a rigorous understanding of drug mechanisms and their therapeutic uses. His role in preclinical research has contributed to the development of safer, more effective drugs, influencing the way treatments for chronic diseases like psoriasis are approached.His research on the pharmacological properties of natural products like Hypericum perforatum has opened new avenues in understanding plant-based therapies, potentially offering more accessible and less invasive treatment options for complex conditions. This focus on both synthetic and natural compounds ensures that his work remains relevant across a broad spectrum of pharmacology.

Legacy and Future Contributions 🚀🔝

As Pranjal Gujarathi continues his journey in pharmacological research, his contributions are likely to have a lasting impact on the field. His focus on innovative drug therapies, coupled with his dedication to teaching, positions him as a significant figure in both the academic and scientific communities. His legacy will be defined not only by the drugs developed under his research but also by the knowledge and inspiration he imparts to his students and colleagues.Looking forward, Pranjal is set to make further strides in drug safety evaluations, exploring new territories in personalized medicine and pharmacovigilance. His work has the potential to revolutionize how we understand drug interactions and their effects on different populations, leading to more personalized and effective treatments for patients around the world.

Conclusion 🌟👨‍⚕️

Pranjal Gujarathi’s journey in pharmacology is a testament to his dedication, intellect, and passion for the field. From his early academic pursuits to his significant professional contributions, he continues to influence the development of new drugs and therapies, pushing the boundaries of what’s possible in pharmacological research. With a future that promises even more innovations, Pranjal’s work is sure to leave a lasting legacy in the realm of pharmaceutical sciences.

Notable Publications 

  • Title: Preclinical techniques for drug discovery in psoriasis
    Authors: Gujarathi, P.P., Korat, R.H., Gujarathi, P.S.
    Journal: International Immunopharmacology
    Year: 2024.
  • Title: Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases
    Authors: Suryawanshi, M.V., Gujarathi, P.P., Mulla, T., Bagban, I.
    Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
    Year: 2024.
  • Title: Evaluation of acute intravenous toxicity of HEPES: Is Good’s buffer good and safe enough for clinical utilization in nuclear medicine?
    Authors: Guleria, M., Pallavi, K.J., Gujarathi, P.P., Das, T.
    Journal: Nuclear Medicine and Biology
    Year: 2024.